|
|
Mammalian Phenotype (MP): abnormal leukocyte cell number 
(show info)
Biomedical Ontology
Like Gene Ontology (GO), biomedical ontology such as phenotype ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Biomedical ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI’s thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology Based on YP which is the major contributor to the ‘Ascomycete phenotype ontology’, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- UniProtKB KeyWords (KW) Ontology Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- CTD Diseases (CD) Ontology CD is MEDIC disease vocabulary that is modified by CTD from the "Diseases" [C] branch of Medical Subject Headings (MeSH), combined with genetic disorders from the Online Mendelian Inheritance in OMIM database.
- CTD Chemicals (CC) Ontology CC is chemical vocabulary that is adapted by CTD from the "Chemicals and Drugs" category and Supplementary Concept Records of Medical Subject Headings (MeSH, a hierarchical vocabulary used to index articles for MEDLINE/PubMed).
Jump to [ Top · Hierarchy · Annotations ]
Root: MP Hierarchy (mammalian/mouse phenotype from MGI_4.41)
Jump to [ Top · Hierarchy ]
Family( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nitric oxide (NO) synthase oxygenase domain | 0 | DIRECT |
| Proteasome subunits | 0 | DIRECT |
| RUNT domain | 0 | DIRECT |
| DNA polymerase beta-like | 0 | DIRECT |
| BAFF receptor-like | 0 | DIRECT |
| Interleukin 17F, IL-17F | 0 | DIRECT |
| DNA polymerase beta-like, second domain | 0 | DIRECT |
| C1 set domains (antibody constant domain-like) | 0.0000003148 | DIRECT |
| Rel/Dorsal transcription factors, DNA-binding domain | 0.00006258 | DIRECT |
| Pyrin domain, PYD | 0.0001677 | DIRECT |
| NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.0004826 | DIRECT |
| ets domain | 0.001053 | INHERITED FROM: decreased thymocyte number |
| Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.001409 | INHERITED FROM: abnormal CD8-positive, alpha-beta T cell number || decreased leukocyte cell number || abnormal T cell number || abnormal CD4-positive, alpha beta T cell number || abnormal lymphocyte cell number || decreased lymphocyte cell number || abnormal neutrophil cell number |
| Interleukin-1 (IL-1) | 0.002483 | INHERITED FROM: increased neutrophil cell number || increased granulocyte number || abnormal neutrophil cell number |
| DNA polymerase beta, N-terminal domain-like | 0.002483 | INHERITED FROM: decreased leukocyte cell number || abnormal lymphocyte cell number || decreased lymphocyte cell number |
| Pointed domain | 0.002779 | INHERITED FROM: decreased leukocyte cell number || abnormal lymphocyte cell number || decreased thymocyte number || decreased lymphocyte cell number |
| Ran binding protein zinc finger-like | 0.008183 | INHERITED FROM: decreased B-1a cell number || decreased B cell number || abnormal B cell number |
| Toll/Interleukin receptor TIR domain | 0.008562 | INHERITED FROM: decreased mature B cell number || increased mature B cell number |
| E2F dimerization segment | 0.008972 | INHERITED FROM: decreased double-positive T cell number || abnormal T cell number |
| Tissue inhibitor of metalloproteinases, TIMP | 0.009052 | INHERITED FROM: increased neutrophil cell number || increased granulocyte number || abnormal granulocyte number || abnormal neutrophil cell number |
| Triple coiled coil domain of C-type lectins | 0.009052 | INHERITED FROM: abnormal monocyte cell number |
| Cytochrome p450 reductase N-terminal domain-like | 0.009052 | INHERITED FROM: increased osteoclast cell number || increased macrophage cell number || abnormal macrophage cell number |
| Bcl-2 inhibitors of programmed cell death | 0.01464 | INHERITED FROM: abnormal mature B cell number || abnormal immature B cell number || increased pre-B cell number || decreased mature B cell number || abnormal T cell number |
| Interferon regulatory factor | 0.01464 | INHERITED FROM: abnormal mature B cell number || decreased T cell number || abnormal plasmacytoid dendritic cell number || decreased mature B cell number || abnormal T cell number || decreased dendritic cell number || decreased plasmacytoid dendritic cell number || increased lymphocyte cell number |
| Phoshoinositide 3-kinase (PI3K) helical domain | 0.02037 | INHERITED FROM: abnormal CD8-positive, alpha-beta T cell number || increased neutrophil cell number || increased granulocyte number || abnormal CD4-positive, alpha beta T cell number || abnormal alpha-beta T cell number || abnormal neutrophil cell number |
| NADPH-cytochrome p450 reductase-like | 0.0269 | INHERITED FROM: increased osteoclast cell number || increased macrophage cell number || abnormal macrophage cell number |
| NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.0269 | INHERITED FROM: increased osteoclast cell number || increased macrophage cell number || abnormal macrophage cell number |
| Nuclear receptor coactivator interlocking domain | 0.0269 | INHERITED FROM: increased T cell number |
| Pleckstrin-homology domain (PH domain) | 0.03408 | INHERITED FROM: decreased transitional stage B cell number |
| SH2 domain | 0.05026 | INHERITED FROM: abnormal immature B cell number || decreased single-positive T cell number || decreased thymocyte number || increased lymphocyte cell number || decreased immature B cell number |
| CCCH zinc finger | 0.05863 | INHERITED FROM: increased mature B cell number |
| Cell cycle transcription factor e2f-dp | 0.05937 | INHERITED FROM: decreased double-positive T cell number |
| Interferon regulatory factor 3 (IRF3), transactivation domain | 0.08837 | INHERITED FROM: absent lymphocyte || abnormal dendritic cell number || abnormal plasmacytoid dendritic cell number || decreased mature B cell number || absent B cells || decreased dendritic cell number || decreased plasmacytoid dendritic cell number || increased B cell number |
| Integrin domains | 0.1087 | INHERITED FROM: decreased CD4-positive, alpha beta T cell number || decreased T cell number || abnormal eosinophil cell number |
| TNF receptor-like | 0.1087 | INHERITED FROM: increased leukocyte cell number || abnormal lymphocyte cell number || increased CD4-positive, alpha beta T cell number |
| DEATH domain, DD | 0.1087 | INHERITED FROM: abnormal lymphocyte cell number || increased transitional stage B cell number |
| MATH domain | 0.1185 | INHERITED FROM: abnormal immature B cell number |
| PLC-like (P variant) | 0.1276 | INHERITED FROM: decreased B-2 B cell number |
| Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) | 0.1276 | INHERITED FROM: decreased thymocyte number |
| DBL homology domain (DH-domain) | 0.132 | INHERITED FROM: decreased transitional stage T2 B cell number || decreased transitional stage B cell number || increased transitional stage B cell number || increased transitional stage T1 B cell number |
| SH3-domain | 0.1355 | INHERITED FROM: decreased single-positive T cell number |
| MHC antigen-recognition domain | 0.1497 | INHERITED FROM: absent CD8-positive, alpha-beta T cells || abnormal T cell number |
| Nuclear receptor ligand-binding domain | 0.1704 | INHERITED FROM: abnormal macrophage cell number |
| Nuclear receptor | 0.1704 | INHERITED FROM: abnormal macrophage cell number |
| V set domains (antibody variable domain-like) | 0.2232 | INHERITED FROM: abnormal T-helper 17 cell number |
| Calponin-homology domain, CH-domain | 0.3434 | INHERITED FROM: decreased transitional stage T2 B cell number || increased transitional stage B cell number || increased transitional stage T1 B cell number |
| Short-chain cytokines | 0.4015 | INHERITED FROM: increased granulocyte number |
| Higher-molecular-weight phosphotyrosine protein phosphatases | 0.5026 | INHERITED FROM: abnormal immature B cell number || increased mature B cell number |
| WWE domain | 0.5354 | INHERITED FROM: abnormal mature B cell number || decreased mature B cell number || decreased marginal zone B cell number |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nitric oxide (NO) synthase oxygenase domain | 0 | Direct |
| Proteasome subunits | 0 | Direct |
| RUNT domain | 0 | Direct |
| DNA polymerase beta-like | 0 | Direct |
| BAFF receptor-like | 0 | Direct |
| Interleukin 17F, IL-17F | 0 | Direct |
| DNA polymerase beta-like, second domain | 0 | Direct |
| C1 set domains (antibody constant domain-like) | 0.0000003148 | Direct |
| Rel/Dorsal transcription factors, DNA-binding domain | 0.00006258 | Direct |
| Pyrin domain, PYD | 0.0001677 | Direct |
| NF-kappa-B/REL/DORSAL transcription factors, C-terminal domain | 0.0004826 | Direct |
| ets domain | 0.001053 | Inherited |
| Phoshoinositide 3-kinase (PI3K), catalytic domain | 0.001409 | Inherited |
| Interleukin-1 (IL-1) | 0.002483 | Inherited |
| DNA polymerase beta, N-terminal domain-like | 0.002483 | Inherited |
| Pointed domain | 0.002779 | Inherited |
| Ran binding protein zinc finger-like | 0.008183 | Inherited |
| Toll/Interleukin receptor TIR domain | 0.008562 | Inherited |
| E2F dimerization segment | 0.008972 | Inherited |
| Tissue inhibitor of metalloproteinases, TIMP | 0.009052 | Inherited |
| Triple coiled coil domain of C-type lectins | 0.009052 | Inherited |
| Cytochrome p450 reductase N-terminal domain-like | 0.009052 | Inherited |
| Bcl-2 inhibitors of programmed cell death | 0.01464 | Inherited |
| Interferon regulatory factor | 0.01464 | Inherited |
| Phoshoinositide 3-kinase (PI3K) helical domain | 0.02037 | Inherited |
| NADPH-cytochrome p450 reductase-like | 0.0269 | Inherited |
| NADPH-cytochrome p450 reductase FAD-binding domain-like | 0.0269 | Inherited |
| Nuclear receptor coactivator interlocking domain | 0.0269 | Inherited |
| Pleckstrin-homology domain (PH domain) | 0.03408 | Inherited |
| SH2 domain | 0.05026 | Inherited |
| CCCH zinc finger | 0.05863 | Inherited |
| Cell cycle transcription factor e2f-dp | 0.05937 | Inherited |
| Interferon regulatory factor 3 (IRF3), transactivation domain | 0.08837 | Inherited |
| Integrin domains | 0.1087 | Inherited |
| TNF receptor-like | 0.1087 | Inherited |
| DEATH domain, DD | 0.1087 | Inherited |
| MATH domain | 0.1185 | Inherited |
| PLC-like (P variant) | 0.1276 | Inherited |
| Protein kinase cysteine-rich domain (cys2, phorbol-binding domain) | 0.1276 | Inherited |
| DBL homology domain (DH-domain) | 0.132 | Inherited |
| SH3-domain | 0.1355 | Inherited |
| MHC antigen-recognition domain | 0.1497 | Inherited |
| Nuclear receptor ligand-binding domain | 0.1704 | Inherited |
| Nuclear receptor | 0.1704 | Inherited |
| V set domains (antibody variable domain-like) | 0.2232 | Inherited |
| Calponin-homology domain, CH-domain | 0.3434 | Inherited |
| Short-chain cytokines | 0.4015 | Inherited |
| Higher-molecular-weight phosphotyrosine protein phosphatases | 0.5026 | Inherited |
| WWE domain | 0.5354 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Single)( show details)
Highlighted in gray are those with FDR>0.001
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Duplex) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
47576,48065
47576 - Calponin-homology domain, CH-domain
48065 - DBL homology domain (DH-domain) | 0 | DIRECT |
55550,55550
55550 - SH2 domain
55550 - SH2 domain | 0 | DIRECT |
81585,81301
81585 - PsbU/PolX domain-like
81301 - Nucleotidyltransferase | 0 | DIRECT |
47802,81585
47802 - DNA polymerase beta, N-terminal domain-like
81585 - PsbU/PolX domain-like | 0 | DIRECT |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.00003745 | DIRECT |
49417,81296
49417 - p53-like transcription factors
81296 - E set domains | 0.00004937 | DIRECT |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0.0005597 | DIRECT |
50729,56112
50729 - PH domain-like
56112 - Protein kinase-like (PK-like) | 0.0006925 | DIRECT |
55550,50044
55550 - SH2 domain
50044 - SH3-domain | 0.002053 | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal immature B cell number || decreased follicular B cell number || abnormal mature B cell number || decreased double-negative T cell number || decreased immature B cell number || increased immature B cell number || increased leukocyte cell number || increased lymphocyte cell number || decreased single-positive T cell number || decreased transitional stage B cell number || increased transitional stage B cell number || decreased mature B cell number || abnormal lymphocyte cell number |
57944,56436
57944 - Triple coiled coil domain of C-type lectins
56436 - C-type lectin-like | 0.008082 | INHERITED FROM: abnormal monocyte cell number |
46785,144074
46785 - "Winged helix" DNA-binding domain
144074 - E2F-DP heterodimerization region | 0.01822 | INHERITED FROM: decreased double-positive T cell number |
49562,48371
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
48371 - ARM repeat | 0.01822 | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal alpha-beta T cell number || increased granulocyte number || increased neutrophil cell number || abnormal neutrophil cell number |
53300,69318
53300 - vWA-like
69318 - Integrin alpha N-terminal domain | 0.03363 | INHERITED FROM: increased alpha-beta T cell number || increased CD8-positive, alpha-beta T cell number || decreased CD4-positive, alpha beta T cell number |
48371,56112
48371 - ARM repeat
56112 - Protein kinase-like (PK-like) | 0.05412 | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || increased neutrophil cell number |
48065,50729
48065 - DBL homology domain (DH-domain)
50729 - PH domain-like | 0.0902 | INHERITED FROM: decreased transitional stage T2 B cell number || increased transitional stage T1 B cell number || decreased transitional stage B cell number || increased transitional stage B cell number |
57667,57667
57667 - beta-beta-alpha zinc fingers
57667 - beta-beta-alpha zinc fingers | 0.1109 | INHERITED FROM: decreased DN2 thymocyte number |
57850,49599
57850 - RING/U-box
49599 - TRAF domain-like | 0.12 | INHERITED FROM: abnormal immature B cell number |
57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like | 0.1708 | INHERITED FROM: increased leukocyte cell number || abnormal lymphocyte cell number || abnormal neutrophil cell number |
48726,48726
48726 - Immunoglobulin
48726 - Immunoglobulin | 0.1747 | INHERITED FROM: absent mast cells |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.2357 | INHERITED FROM: decreased T cell number |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.2357 | INHERITED FROM: decreased T cell number |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.2418 | INHERITED FROM: abnormal macrophage cell number |
50044,55550
50044 - SH3-domain
55550 - SH2 domain | 0.4478 | INHERITED FROM: abnormal immature B cell number || decreased immature B cell number || decreased single-positive T cell number |
50729,55550
50729 - PH domain-like
55550 - SH2 domain | 0.4491 | INHERITED FROM: abnormal B cell number || increased neutrophil cell number || increased lymphocyte cell number || decreased B cell number || abnormal neutrophil cell number |
55550,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.524 | INHERITED FROM: decreased leukocyte cell number |
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
47576,48065
47576 - Calponin-homology domain, CH-domain
48065 - DBL homology domain (DH-domain) | 0 | Direct |
55550,55550
55550 - SH2 domain
55550 - SH2 domain | 0 | Direct |
81585,81301
81585 - PsbU/PolX domain-like
81301 - Nucleotidyltransferase | 0 | Direct |
47802,81585
47802 - DNA polymerase beta, N-terminal domain-like
81585 - PsbU/PolX domain-like | 0 | Direct |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.00003745 | Direct |
49417,81296
49417 - p53-like transcription factors
81296 - E set domains | 0.00004937 | Direct |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0.0005597 | Direct |
50729,56112
50729 - PH domain-like
56112 - Protein kinase-like (PK-like) | 0.0006925 | Direct |
55550,50044
55550 - SH2 domain
50044 - SH3-domain | 0.002053 | Inherited |
57944,56436
57944 - Triple coiled coil domain of C-type lectins
56436 - C-type lectin-like | 0.008082 | Inherited |
46785,144074
46785 - "Winged helix" DNA-binding domain
144074 - E2F-DP heterodimerization region | 0.01822 | Inherited |
49562,48371
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
48371 - ARM repeat | 0.01822 | Inherited |
53300,69318
53300 - vWA-like
69318 - Integrin alpha N-terminal domain | 0.03363 | Inherited |
48371,56112
48371 - ARM repeat
56112 - Protein kinase-like (PK-like) | 0.05412 | Inherited |
48065,50729
48065 - DBL homology domain (DH-domain)
50729 - PH domain-like | 0.0902 | Inherited |
57667,57667
57667 - beta-beta-alpha zinc fingers
57667 - beta-beta-alpha zinc fingers | 0.1109 | Inherited |
57850,49599
57850 - RING/U-box
49599 - TRAF domain-like | 0.12 | Inherited |
57586,57586
57586 - TNF receptor-like
57586 - TNF receptor-like | 0.1708 | Inherited |
48726,48726
48726 - Immunoglobulin
48726 - Immunoglobulin | 0.1747 | Inherited |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.2357 | Inherited |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.2357 | Inherited |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.2418 | Inherited |
50044,55550
50044 - SH3-domain
55550 - SH2 domain | 0.4478 | Inherited |
50729,55550
50729 - PH domain-like
55550 - SH2 domain | 0.4491 | Inherited |
55550,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.524 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Triple) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550
50729 - PH domain-like
50044 - SH3-domain
55550 - SH2 domain | 0 | DIRECT |
50044,55550,50044
50044 - SH3-domain
55550 - SH2 domain
50044 - SH3-domain | 0 | DIRECT |
47576,48065,50729
47576 - Calponin-homology domain, CH-domain
48065 - DBL homology domain (DH-domain)
50729 - PH domain-like | 0 | DIRECT |
47802,81585,81301
47802 - DNA polymerase beta, N-terminal domain-like
81585 - PsbU/PolX domain-like
81301 - Nucleotidyltransferase | 0 | DIRECT |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.001163 | INHERITED FROM: decreased leukocyte cell number |
49562,48371,56112
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
48371 - ARM repeat
56112 - Protein kinase-like (PK-like) | 0.01822 | INHERITED FROM: abnormal CD4-positive, alpha beta T cell number || abnormal CD8-positive, alpha-beta T cell number || abnormal alpha-beta T cell number || increased granulocyte number || increased neutrophil cell number || abnormal neutrophil cell number |
53300,69318,69179
53300 - vWA-like
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.03363 | INHERITED FROM: increased alpha-beta T cell number || increased CD8-positive, alpha-beta T cell number || decreased CD4-positive, alpha beta T cell number |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.2357 | INHERITED FROM: decreased T cell number |
48726,48726,48726
48726 - Immunoglobulin
48726 - Immunoglobulin
48726 - Immunoglobulin | 0.3135 | INHERITED FROM: absent mast cells |
50044,55550,56112
50044 - SH3-domain
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.5128 | INHERITED FROM: decreased leukocyte cell number |
55550,56112,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.528 | INHERITED FROM: abnormal B cell number || decreased T cell number || increased lymphocyte cell number || decreased B cell number |
50729,55550,56112
50729 - PH domain-like
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.528 | INHERITED FROM: abnormal B cell number || decreased T cell number || increased lymphocyte cell number || decreased B cell number |
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
50729,50044,55550
50729 - PH domain-like
50044 - SH3-domain
55550 - SH2 domain | 0 | Direct |
50044,55550,50044
50044 - SH3-domain
55550 - SH2 domain
50044 - SH3-domain | 0 | Direct |
47576,48065,50729
47576 - Calponin-homology domain, CH-domain
48065 - DBL homology domain (DH-domain)
50729 - PH domain-like | 0 | Direct |
47802,81585,81301
47802 - DNA polymerase beta, N-terminal domain-like
81585 - PsbU/PolX domain-like
81301 - Nucleotidyltransferase | 0 | Direct |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.001163 | Inherited |
49562,48371,56112
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
48371 - ARM repeat
56112 - Protein kinase-like (PK-like) | 0.01822 | Inherited |
53300,69318,69179
53300 - vWA-like
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.03363 | Inherited |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.2357 | Inherited |
48726,48726,48726
48726 - Immunoglobulin
48726 - Immunoglobulin
48726 - Immunoglobulin | 0.3135 | Inherited |
50044,55550,56112
50044 - SH3-domain
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.5128 | Inherited |
55550,56112,56112
55550 - SH2 domain
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.528 | Inherited |
50729,55550,56112
50729 - PH domain-like
55550 - SH2 domain
56112 - Protein kinase-like (PK-like) | 0.528 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Plot distribution on species Tree Of Life (sTOL) for Superfamily and/or Family domains annotated by this MP term
 |
Plot tree as:
| |
Download Newick format tree:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Plot distribution on species Tree Of Life (sTOL) for single supra-domains annotated by this MP term
|
Plot tree as:
| |
Download Newick format tree:
| |
Browsing in TREE OF LIFE:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|
|
> BO Hierarchy > abnormal leukocyte cell number
